— Know what they know.
Not Investment Advice

MGRX

Mangoceuticals, Inc.
1W: -11.7% 1M: -37.2% 3M: -58.0% YTD: -61.5% 1Y: -93.1%
$0.33
+0.03 (+8.31%)
After Hours: $0.31 (-0.02, -4.67%)
NASDAQ · Healthcare · Medical - Healthcare Information Services · $3.8M · Alpha Radar Sell · Power 33
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$3.8M
52W Range0.162-5.2
Volume2,505,764
Avg Volume7,464,688
Beta2.33
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOJacob D. Cohen
Employees3
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2023-03-21
15110 North Dallas Parkway
Dallas, TX 75248
US
(214) 242-9619
About Mangoceuticals, Inc.

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Recent Insider Trades

NameTypeSharesPriceDate
Cohen Jacob D. D-Return 50,000 $16.50 2026-03-16
Cohen Jacob D. A-Award 50,000 $0.45 2026-03-16
Cohen Jacob D. D-Return 83,333 $4.80 2026-03-16
Cohen Jacob D. A-Award 83,333 $0.45 2026-03-16
Cohen Jacob D. D-Return 2,000,000 $2.30 2026-03-16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms